PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.\', \'Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.\', \'Department of Neurology, University of California San Francisco, San Francisco, CA, USA.\', \'Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.\', \'UK Dementia Research Institute at UCL, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jnc.15459
?:hasPublicationType
?:journal
  • Journal of neurochemistry
is ?:pmid of
?:pmid
?:pmid
  • 34170549
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.978
?:rankingScore_hIndex
  • 207
is ?:relation_isRelatedTo_publication of
?:title
  • Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all